sprite-preloader
Anzeige
Mehr »
Samstag, 23.09.2017 Börsentäglich über 12.000 News von 561 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: A2DHL5 ISIN: US29414D1000 Ticker-Symbol: N16 
Aktie:
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
ENVISION HEALTHCARE CORPORATION Chart 1 Jahr
1-Woche-Intraday-Chart
ENVISION HEALTHCARE CORPORATION 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
37,31
37,53
22.09.
15.09.2017 | 17:45
(4 Leser)
Schrift ändern:
(0 Bewertungen)

ACCESSWIRE·Mehr Nachrichten von ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / September 15, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Middle District of Tennessee on behalf of investors who purchased Envision Healthcare Corporation ("Envision Healthcare") (NYSE: EVHC) securities between March 2, 2015 and July 21, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sb/envision-healthcare-corporation?wire=1. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (i) Envision Healthcare's subsidiary, EmCare Holdings, Inc., routinely arranged for patients who sought treatment at in-network facilities to be treated by out-of-network physicians; (ii) EmCare accordingly billed these patients at higher rates than if the patients had received treatment from in-network physicians; (iii) the Company's statements attributing EmCare's Class Period growth to other factors were therefore false and/or misleading; (iv) Envision's EmCare revenues were likely to be unsustainable after the foregoing conduct came to light; and (v) as a result of the foregoing, Envision's public statements were materially false and misleading at all relevant times.

If you suffered a loss in Envision Healthcare, you have until October 3, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sb/envision-healthcare-corporation?wire=1.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong


© 2017 ACCESSWIRE